{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:45Z","timestamp":1791388125527,"version":"4.3.3"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES025128"],"award-info":[{"award-number":["P30ES025128"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES025128"],"award-info":[{"award-number":["P30ES025128"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["1R21AT011371-01A1"],"award-info":[{"award-number":["1R21AT011371-01A1"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["1R21AT011371-01A1"],"award-info":[{"award-number":["1R21AT011371-01A1"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2144912"],"award-info":[{"award-number":["2144912"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prenatal brain development is particularly sensitive to chemicals that can disrupt synapse formation and cause neurodevelopmental disorders. In most cases, such chemicals increase cellular oxidative stress. For example, prenatal exposure to the anti-epileptic drug valproic acid (VPA), induces oxidative stress and synaptic alterations, promoting autism spectrum disorders (ASD) in humans and autism-like behaviors in rodents. Using VPA to model chemically induced ASD, we tested whether activation of cellular mechanisms that increase antioxidant gene expression would be sufficient to prevent VPA-induced synaptic alterations. As a master regulator of cellular defense pathways, the transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) promotes expression of detoxification enzymes and antioxidant gene products. To increase NRF2 activity, we used the phytochemical and potent NRF2 activator, sulforaphane (SFN). In our models of human neurodevelopment, SFN activated NRF2, increasing expression of antioxidant genes and preventing oxidative stress. SFN also enhanced expression of genes associated with synapse formation. Consistent with these gene expression profiles, SFN protected developing neural networks from VPA-induced reductions in synapse formation. Furthermore, in mouse cortical neurons, SFN rescued VPA-induced reductions in neural activity. These results demonstrate the ability of SFN to protect developing neural networks during the vulnerable period of synapse formation, while also identifying molecular signatures of SFN-mediated neuroprotection that could be relevant for combatting other environmental toxicants.<\/jats:p>","DOI":"10.1038\/s41380-025-02967-5","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T22:21:32Z","timestamp":1743805292000},"page":"3868-3884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Sulforaphane protects developing neural networks from VPA-induced synaptic alterations"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-1603","authenticated-orcid":false,"given":"Riley N.","family":"Bessetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0049-5760","authenticated-orcid":false,"given":"Michelle","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario M.","family":"Lilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah Z.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5148-5269","authenticated-orcid":false,"given":"Daisy A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.","family":"Koonce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-3486","authenticated-orcid":false,"given":"Karen A.","family":"Litwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"2967_CR1","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.3402\/ehtj.v4i0.7111","volume":"4","author":"RR Dietert","year":"2011","unstructured":"Dietert RR, Dietert JM, Dewitt JC. Environmental risk factors for autism. Emerg Health Threats J. 2011;4:7111.","journal-title":"Emerg Health Threats J"},{"key":"2967_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.envint.2015.12.021","volume":"88","author":"LA Sealey","year":"2016","unstructured":"Sealey LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, et al. Environmental factors in the development of autism spectrum disorders. Environ Int. 2016;88:288\u201398.","journal-title":"Environ Int"},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2174\/0109298673252471231121045529","volume":"31","author":"K Yenkoyan","year":"2024","unstructured":"Yenkoyan K, Mkhitaryan M, Bj\u00f8rklund G. Environmental risk factors in autism spectrum disorder: a narrative review. Curr Med Chem. 2024;31:2345\u201360.","journal-title":"Curr Med Chem"},{"key":"2967_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00018-018-2988-4","volume":"76","author":"S B\u00f6lte","year":"2019","unstructured":"B\u00f6lte S, Girdler S, Marschik PB. The contribution of environmental exposure to the etiology of autism spectrum disorder. Cell Mol Life Sci. 2019;76:1275\u201397.","journal-title":"Cell Mol Life Sci"},{"key":"2967_CR5","doi-asserted-by":"publisher","first-page":"813304","DOI":"10.3389\/fpsyt.2022.813304","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Lin J, Zhang H, Khan NU, Zhang J, Tang X, et al. Oxidative stress in autism spectrum disorder\u2014current progress of mechanisms and biomarkers. Front Psychiatry. 2022;13:813304.","journal-title":"Front Psychiatry"},{"key":"2967_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40572-018-0185-0","volume":"5","author":"KD Rock","year":"2018","unstructured":"Rock KD, Patisaul HB. Environmental mechanisms of neurodevelopmental toxicity. Curr Environ Health Rep. 2018;5:145\u201357.","journal-title":"Curr Environ Health Rep"},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/1873-3468.12972","volume":"592","author":"MCW Oswald","year":"2018","unstructured":"Oswald MCW, Garnham N, Sweeney ST, Landgraf M. Regulation of neuronal development and function by ROS. FEBS Lett. 2018;592:679\u201391.","journal-title":"FEBS Lett"},{"key":"2967_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1471-4159.2008.05787.x","volume":"108","author":"V Munnamalai","year":"2009","unstructured":"Munnamalai V, Suter DM. Reactive oxygen species regulate f-actin dynamics in neuronal growth cones and neurite outgrowth. J Neurochem. 2009;108:644\u201361.","journal-title":"J Neurochem"},{"key":"2967_CR9","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2010.3208","volume":"14","author":"CA Massaad","year":"2011","unstructured":"Massaad CA, Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal. 2011;14:2013\u201354.","journal-title":"Antioxid Redox Signal"},{"issue":"Suppl 1","key":"2967_CR10","first-page":"23","volume":"10","author":"TF Beckhauser","year":"2016","unstructured":"Beckhauser TF, Francis-Oliveira J, De Pasquale R. Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity. J Exp Neurosci. 2016;10(Suppl 1):23\u201348.","journal-title":"J Exp Neurosci"},{"key":"2967_CR11","doi-asserted-by":"crossref","unstructured":"Ansari MA, Rao MS, Al-Jarallah, A. Insights into early pathogenesis of sporadic Alzheimer\u2019s disease: role of oxidative stress and loss of synaptic proteins. Front Neurosci. 2024;17:1273626.","DOI":"10.3389\/fnins.2023.1273626"},{"key":"2967_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1042\/EBC20190052","volume":"64","author":"N Campolo","year":"2020","unstructured":"Campolo N, Issoglio FM, Estrin DA, Bartesaghi S, Radi R. 3-nitrotyrosine and related derivatives in proteins: precursors, radical intermediates and impact in function. Essays Biochem. 2020;64:111\u201333.","journal-title":"Essays Biochem"},{"key":"2967_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1080\/00207454.2020.1713776","volume":"130","author":"M Bandookwala","year":"2020","unstructured":"Bandookwala M, Sengupta P. 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases. Int J Neurosci. 2020;130:1047\u201362.","journal-title":"Int J Neurosci"},{"key":"2967_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2016.03.001","volume":"95","author":"TJ van \u2018t Erve","year":"2016","unstructured":"van \u2018t Erve TJ, Lih FB, Jelsema C, Deterding LJ, Eling TE, Mason RP, et al. Reinterpreting the best biomarker of oxidative stress:The 8-iso-prostaglandin F2\u03b1\/prostaglandin F2\u03b1 ratio shows complex origins of lipid peroxidation biomarkers in animal models. Free Radic Biol Med. 2016;95:65\u201373.","journal-title":"Free Radic Biol Med"},{"key":"2967_CR15","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/s12276-022-00822-z","volume":"54","author":"JY Hahm","year":"2022","unstructured":"Hahm JY, Park J, Jang ES, Chi SW. 8-oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification. Exp Mol Med. 2022;54:1626\u201342.","journal-title":"Exp Mol Med"},{"key":"2967_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s12311-010-0223-4","volume":"10","author":"EM Sajdel-Sulkowska","year":"2011","unstructured":"Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N. Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). The Cerebellum. 2011;10:43\u20138.","journal-title":"The Cerebellum"},{"key":"2967_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0183-3","volume":"9","author":"A Anwar","year":"2018","unstructured":"Anwar A, Abruzzo PM, Pasha S, Rajpoot K, Bolotta A, Ghezzo A, et al. Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis. Mol Autism. 2018;9:3.","journal-title":"Mol Autism"},{"key":"2967_CR18","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/tp.2012.61","volume":"2","author":"S Rose","year":"2012","unstructured":"Rose S, Melnyk S, Pavliv O, Bai S, Nick TG, Frye RE, et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry. 2012;2:e134.","journal-title":"Transl Psychiatry"},{"key":"2967_CR19","doi-asserted-by":"publisher","first-page":"343824","DOI":"10.1155\/2013\/343824","volume":"2013","author":"C Signorini","year":"2013","unstructured":"Signorini C, De Felice C, Durand T, Oger C, Galano JM, Leoncini S, et al. Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on rett syndrome as a model of autism spectrum disorder. Oxid Med Cell Longev. 2013;2013:343824.","journal-title":"Oxid Med Cell Longev"},{"key":"2967_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.plefa.2005.06.002","volume":"73","author":"X Ming","year":"2005","unstructured":"Ming X, Stein TP, Brimacombe M, Johnson WG, Lambert GH, Wagner GC. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids. 2005;73:379\u201384.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2967_CR21","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s11011-017-0083-4","volume":"32","author":"B Pop","year":"2017","unstructured":"Pop B, Niculae A\u0218, Pop TL, R\u0103chi\u0219an AL. Individuals with autism have higher 8-Iso-PGF2\u03b1 levels than controls, but no correlation with quantitative assay of Paraoxonase 1 serum levels. Metab Brain Dis. 2017;32:1943\u201350.","journal-title":"Metab Brain Dis"},{"key":"2967_CR22","doi-asserted-by":"publisher","first-page":"e00099","DOI":"10.1128\/MCB.00099-20","volume":"40","author":"L Baird","year":"2020","unstructured":"Baird L, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40:e00099\u201320.","journal-title":"Mol Cell Biol"},{"key":"2967_CR23","doi-asserted-by":"publisher","first-page":"21592","DOI":"10.1074\/jbc.M300931200","volume":"278","author":"M McMahon","year":"2003","unstructured":"McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression*. J Biol Chem. 2003;278:21592\u2013600.","journal-title":"J Biol Chem"},{"key":"2967_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2019.06.047","volume":"28","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Muramatsu A, Saito R, Iso T, Shibata T, Kuwata K, et al. Molecular mechanism of cellular oxidative stress sensing by Keap1. Cell Rep. 2019;28:746\u2013758.e4.","journal-title":"Cell Rep"},{"key":"2967_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2. Antioxid Redox Signal. 2018;29:1727\u201345.","journal-title":"Antioxid Redox Signal"},{"key":"2967_CR26","first-page":"e220021","volume":"2023","author":"Y Abiko","year":"2023","unstructured":"Abiko Y, Toriba A, Kumagai Y. Phytochemicals to regulate oxidative and electrophilic stress through Nrf2 activation. Redox Exp Med. 2023;2023:e220021.","journal-title":"Redox Exp Med"},{"key":"2967_CR27","doi-asserted-by":"publisher","first-page":"7857186","DOI":"10.1155\/2016\/7857186","volume":"2016","author":"CA Houghton","year":"2016","unstructured":"Houghton CA, Fassett RG, Coombes JS. Sulforaphane and other nutrigenomic Nrf2 activators: can the Clinician\u2019s expectation be matched by the reality? Oxid Med Cell Longev. 2016;2016:7857186.","journal-title":"Oxid Med Cell Longev"},{"key":"2967_CR28","doi-asserted-by":"publisher","first-page":"827527","DOI":"10.3389\/fncel.2022.827527","volume":"16","author":"X Li","year":"2022","unstructured":"Li X, Ying H, Zhang Z, Yang Z, You C, Cai X, et al. Sulforaphane attenuates chronic intermittent hypoxia-induced brain damage in mice via augmenting Nrf2 nuclear translocation and autophagy. Front Cell Neurosci. 2022;16:827527.","journal-title":"Front Cell Neurosci."},{"key":"2967_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.biopha.2018.05.031","volume":"104","author":"GB Corssac","year":"2018","unstructured":"Corssac GB, Campos-Carraro C, Hickmann A, da Rosa Araujo AS, Fernandes RO, Bell\u00f3-Klein A. Sulforaphane effects on oxidative stress parameters in culture of adult cardiomyocytes. Biomed Pharmacother. 2018;104:165\u201371.","journal-title":"Biomed Pharmacother"},{"key":"2967_CR30","first-page":"6902","volume":"28","author":"RA Otoo","year":"2023","unstructured":"Otoo RA, Allen AR. Sulforaphane\u2019s multifaceted potential: from neuroprotection to anticancer action. Mol Basel Switz. 2023;28:6902.","journal-title":"Mol Basel Switz"},{"key":"2967_CR31","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1073\/pnas.94.19.10367","volume":"94","author":"JW Fahey","year":"1997","unstructured":"Fahey JW, Zhang Y, Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against\u2009chemical\u2009carcinogens. Proc Natl Acad Sci. 1997;94:10367\u201372.","journal-title":"Proc Natl Acad Sci"},{"key":"2967_CR32","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3390\/foods10081927","volume":"10","author":"J T\u0159\u00edska","year":"2021","unstructured":"T\u0159\u00edska J, Bal\u00edk J, Hou\u0161ka M, Novotn\u00e1 P, Magner M, Vrchotov\u00e1 N, et al. Factors influencing sulforaphane content in broccoli sprouts and subsequent sulforaphane extraction. Foods. 2021;10:1927.","journal-title":"Foods"},{"key":"2967_CR33","doi-asserted-by":"publisher","first-page":"116177","DOI":"10.1016\/j.taap.2022.116177","volume":"451","author":"CM Amato","year":"2022","unstructured":"Amato CM, Fricke A, Marella S, Mogus JP, Bereman M, McCoy KA. An experimental evaluation of the efficacy of perinatal sulforaphane supplementation to decrease the incidence and severity of vinclozolin-induced hypospadias in the mouse model. Toxicol Appl Pharmacol. 2022;451:116177.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2967_CR34","doi-asserted-by":"publisher","first-page":"e0248777","DOI":"10.1371\/journal.pone.0248777","volume":"16","author":"Z Ladak","year":"2021","unstructured":"Ladak Z, Garcia E, Yoon J, Landry T, Armstrong EA, Yager JY, et al. Sulforaphane (SFA) protects neuronal cells from oxygen & glucose deprivation (OGD). PLoS ONE. 2021;16:e0248777.","journal-title":"PLoS ONE"},{"key":"2967_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/glia.20793","volume":"57","author":"CA Danilov","year":"2009","unstructured":"Danilov CA, Chandrasekaran K, Racz J, Soane L, Zielke C, Fiskum G. Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia. 2009;57:645\u201356.","journal-title":"Glia"},{"key":"2967_CR36","doi-asserted-by":"publisher","first-page":"8097","DOI":"10.1021\/acs.jafc.2c01978","volume":"70","author":"X Zhang","year":"2022","unstructured":"Zhang X, Chen Y, Li H, Chen B, Liu Z, Wu G, et al. Sulforaphane acts through NFE2L2 to prevent hypoxia-induced apoptosis in porcine granulosa cells via activating antioxidant defenses and mitophagy. J Agric Food Chem. 2022;70:8097\u2013110.","journal-title":"J Agric Food Chem"},{"key":"2967_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.placenta.2020.09.001","volume":"101","author":"A Langston-Cox","year":"2020","unstructured":"Langston-Cox A, Leo CH, Tare M, Wallace EM, Marshall SA. Sulforaphane improves vascular reactivity in mouse and human arteries after \u201cpreeclamptic-like\u201d injury. Placenta. 2020;101:242\u201350.","journal-title":"Placenta"},{"key":"2967_CR38","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s43032-020-00439-5","volume":"28","author":"AG Langston-Cox","year":"2021","unstructured":"Langston-Cox AG, Anderson D, Creek DJ, Palmer KR, Marshall SA, Wallace EM. Sulforaphane bioavailability and effects on blood pressure in women with pregnancy hypertension. Reprod Sci Thousand Oaks Calif. 2021;28:1489\u201397.","journal-title":"Reprod Sci Thousand Oaks Calif"},{"key":"2967_CR39","first-page":"643","volume":"38","author":"DA Butterfield","year":"2023","unstructured":"Butterfield DA, Boyd-Kimball D, Reed TT. Cellular stress response (hormesis) in response to bioactive nutraceuticals with relevance to alzheimer disease. Antioxid Redox Signal. 2023;38:643\u201369.","journal-title":"Antioxid Redox Signal"},{"key":"2967_CR40","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3390\/ijms22062929","volume":"22","author":"J Kim","year":"2021","unstructured":"Kim J. Pre-clinical neuroprotective evidences and plausible mechanisms of sulforaphane in Alzheimer\u2019s disease. Int J Mol Sci. 2021;22:2929.","journal-title":"Int J Mol Sci"},{"key":"2967_CR41","doi-asserted-by":"publisher","first-page":"10707","DOI":"10.3390\/ijms221910707","volume":"22","author":"N Cichon","year":"2021","unstructured":"Cichon N, Dziedzic A, Gorniak L, Miller E, Bijak M, Starosta M, et al. Unusual bioactive compounds with antioxidant properties in adjuvant therapy supporting cognition impairment in age-related neurodegenerative disorders. Int J Mol Sci. 2021;22:10707.","journal-title":"Int J Mol Sci"},{"key":"2967_CR42","first-page":"154582","volume":"109","author":"X Bai","year":"2023","unstructured":"Bai X, Bian Z, Zhang M. Targeting the Nrf2 signaling pathway using phytochemical ingredients: a novel therapeutic road map to combat neurodegenerative diseases. Phytomedicine Int J Phytother Phytopharm. 2023;109:154582.","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"key":"2967_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0218-4","volume":"9","author":"S Bent","year":"2018","unstructured":"Bent S, Lawton B, Warren T, Widjaja F, Dang K, Fahey JW, et al. Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli. Mol Autism. 2018;9:35.","journal-title":"Mol Autism"},{"key":"2967_CR44","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11011-023-01224-4","volume":"39","author":"A Shah","year":"2023","unstructured":"Shah A, Varma M, Bhandari R. Exploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD. Metab Brain Dis. 2023;39:373\u201385. https:\/\/doi.org\/10.1007\/s11011-023-01224-4.","journal-title":"Metab Brain Dis"},{"key":"2967_CR45","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1089\/ars.2010.3731","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo A, Innamorato N, Hesse M, Fern\u00e1ndez-Ruiz J, Cuadrado A. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism. Antioxid Redox Signal. 2011;14:2347\u201360.","journal-title":"Antioxid Redox Signal"},{"key":"2967_CR46","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1073\/pnas.1416940111","volume":"111","author":"K Singh","year":"2014","unstructured":"Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci. 2014;111:15550\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"2967_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2019.03.010","volume":"853","author":"C Huang","year":"2019","unstructured":"Huang C, Wu J, Chen D, Jin J, Wu Y, Chen Z. Effects of sulforaphane in the central nervous system. Eur J Pharmacol. 2019;853:153\u201368.","journal-title":"Eur J Pharmacol"},{"key":"2967_CR48","doi-asserted-by":"publisher","first-page":"e2021053012","DOI":"10.1542\/peds.2021-053012","volume":"149","author":"HE Volk","year":"2021","unstructured":"Volk HE, Ames JL, Chen A, Fallin MD, Hertz-Picciotto I, Halladay A, et al. Considering toxic chemicals in the etiology of autism. Pediatrics. 2021;149:e2021053012.","journal-title":"Pediatrics"},{"key":"2967_CR49","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Gr\u00f8nborg TK, S\u00f8rensen MJ, Schendel D, Parner ET, Pedersen LH, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013;309:1696\u2013703.","journal-title":"JAMA"},{"key":"2967_CR50","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exp Neurol. 2018;299:217\u201327.","journal-title":"Exp Neurol"},{"key":"2967_CR51","doi-asserted-by":"publisher","first-page":"111322","DOI":"10.1016\/j.biopha.2021.111322","volume":"137","author":"A Taleb","year":"2021","unstructured":"Taleb A, Lin W, Xu X, Zhang G, Zhou QG, Naveed M, et al. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment. Biomed Pharmacother. 2021;137:111322.","journal-title":"Biomed Pharmacother"},{"key":"2967_CR52","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1124\/mol.111.072314","volume":"80","author":"EWY Tung","year":"2011","unstructured":"Tung EWY, Winn LM. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol. 2011;80:979\u201387.","journal-title":"Mol Pharmacol"},{"key":"2967_CR53","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1080\/03602530600959433","volume":"38","author":"TKH Chang","year":"2006","unstructured":"Chang TKH, Abbott FS. Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity. Drug Metab Rev. 2006;38:627\u201339.","journal-title":"Drug Metab Rev"},{"key":"2967_CR54","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jpeds.2006.08.015","volume":"149","author":"A Michoulas","year":"2006","unstructured":"Michoulas A, Tong V, Teng XW, Chang TKH, Abbott FS, Farrell K. Oxidative stress in children receiving valproic acid. J Pediatr. 2006;149:692\u20136.","journal-title":"J Pediatr"},{"key":"2967_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/antiox9060521","volume":"9","author":"RT Ruhee","year":"2020","unstructured":"Ruhee RT, Suzuki K. The integrative role of sulforaphane in preventing inflammation, oxidative stress and fatigue: a review of a potential protective phytochemical. Antioxidants. 2020;9:521.","journal-title":"Antioxidants"},{"key":"2967_CR56","first-page":"18","volume":"123","author":"TB Piorczynski","year":"2022","unstructured":"Piorczynski TB, Larsen MW, Lee SJ, Hansen JM. NRF2 activation protects against valproic acid-induced disruption of neurogenesis in P19 cells. Differ Res Biol Divers. 2022;123:18\u201329.","journal-title":"Differ Res Biol Divers"},{"key":"2967_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41416-021-01570-z","volume":"126","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Southam AD, Trova S, Beke F, Alhazmi B, Francis T, et al. Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing. Br J Cancer. 2022;126:275\u201386.","journal-title":"Br J Cancer"},{"key":"2967_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2014.01.021","volume":"121","author":"P Palsamy","year":"2014","unstructured":"Palsamy P, Bidasee KR, Shinohara T. Valproic acid suppresses Nrf2\/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells. Exp Eye Res. 2014;121:26\u201334.","journal-title":"Exp Eye Res"},{"key":"2967_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01898-x","volume":"12","author":"Q Meng","year":"2022","unstructured":"Meng Q, Zhang W, Wang X, Jiao C, Xu S, Liu C, et al. Human forebrain organoids reveal connections between valproic acid exposure and autism risk. Transl Psychiatry. 2022;12:130.","journal-title":"Transl Psychiatry"},{"key":"2967_CR60","doi-asserted-by":"publisher","first-page":"1023765","DOI":"10.3389\/fnmol.2022.1023765","volume":"15","author":"Z Zang","year":"2022","unstructured":"Zang Z, Yin H, Du Z, Xie R, Yang L, Cai Y, et al. Valproic acid exposure decreases neurogenic potential of outer radial glia in human brain organoids. Front Mol Neurosci. 2022;15:1023765.","journal-title":"Front Mol Neurosci"},{"key":"2967_CR61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41378-020-0165-z","volume":"6","author":"K Cui","year":"2020","unstructured":"Cui K, Wang Y, Zhu Y, Tao T, Yin F, Guo Y, et al. Neurodevelopmental impairment induced by prenatal valproic acid exposure shown with the human cortical organoid-on-a-chip model. Microsyst Nanoeng. 2020;6:49.","journal-title":"Microsyst Nanoeng"},{"key":"2967_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73177-y","volume":"10","author":"E Wilson","year":"2020","unstructured":"Wilson E, Knudson W, Newell-Litwa K. Hyaluronan regulates synapse formation and function in developing neural networks. Sci Rep. 2020;10:16459.","journal-title":"Sci Rep"},{"key":"2967_CR63","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/jnr.24692","volume":"98","author":"E Wilson","year":"2020","unstructured":"Wilson E, Rudisill T, Kirk B, Johnson C, Kemper P, Newell-Litwa K. Cytoskeletal regulation of synaptogenesis in a model of human fetal brain development. J Neurosci Res. 2020;98:2148\u201365.","journal-title":"J Neurosci Res"},{"key":"2967_CR64","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09915","volume":"473","author":"KJ Brennand","year":"2011","unstructured":"Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature. 2011;473:221\u20135.","journal-title":"Nature"},{"key":"2967_CR65","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.stemcr.2017.06.018","volume":"9","author":"J Tcw","year":"2017","unstructured":"Tcw J, Wang M, Pimenova AA, Bowles KR, Hartley BJ, Lacin E, et al. An efficient platform for astrocyte differentiation from human induced pluripotent stem cells. Stem Cell Rep. 2017;9:600\u201314.","journal-title":"Stem Cell Rep"},{"key":"2967_CR66","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1254\/jphs.10257FP","volume":"115","author":"K Mizuno","year":"2011","unstructured":"Mizuno K, Kume T, Muto C, Takada-Takatori Y, Izumi Y, Sugimoto H, et al. Glutathione biosynthesis via activation of the nuclear factor E2\u2013related factor 2 (Nrf2) \u2013 Antioxidant-Response Element (ARE) pathway is essential for neuroprotective effects of sulforaphane and 6-(Methylsulfinyl) hexyl isothiocyanate. J Pharmacol Sci. 2011;115:320\u20138.","journal-title":"J Pharmacol Sci"},{"key":"2967_CR67","doi-asserted-by":"publisher","first-page":"e92980","DOI":"10.1371\/journal.pone.0092980","volume":"9","author":"JMP Ferreira de Oliveira","year":"2014","unstructured":"Ferreira de Oliveira JMP, Costa M, Pedrosa T, Pinto P, Rem\u00e9dios C, Oliveira H, et al. Sulforaphane induces oxidative stress and death by p53-independent mechanism: implication of impaired glutathione recycling. PLoS ONE. 2014;9:e92980.","journal-title":"PLoS ONE"},{"key":"2967_CR68","doi-asserted-by":"publisher","first-page":"104728","DOI":"10.1016\/j.neuint.2020.104728","volume":"136","author":"L Tang","year":"2020","unstructured":"Tang L, Ren X, Han Y, Chen L, Meng X, Zhang C, et al. Sulforaphane attenuates apoptosis of hippocampal neurons induced by high glucose via regulating endoplasmic reticulum. Neurochem Int. 2020;136:104728.","journal-title":"Neurochem Int"},{"key":"2967_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12264-012-1273-z","volume":"28","author":"X Wu","year":"2012","unstructured":"Wu X, Zhao J, Yu S, Chen Y, Wu J, Zhao Y. Sulforaphane protects primary cultures of cortical neurons against injury induced by oxygen-glucose deprivation\/reoxygenation via antiapoptosis. Neurosci Bull. 2012;28:509\u201316.","journal-title":"Neurosci Bull"},{"key":"2967_CR70","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bcp.13510","volume":"84","author":"J Methaneethorn","year":"2018","unstructured":"Methaneethorn J. A systematic review of population pharmacokinetics of valproic acid. Br J Clin Pharmacol. 2018;84:816\u201334.","journal-title":"Br J Clin Pharmacol"},{"key":"2967_CR71","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1073\/pnas.0407643101","volume":"101","author":"J Hsieh","year":"2004","unstructured":"Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci. 2004;101:16659\u201364.","journal-title":"Proc Natl Acad Sci"},{"key":"2967_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41380-018-0056-y","volume":"24","author":"E Courchesne","year":"2019","unstructured":"Courchesne E, Pramparo T, Gazestani VH, Lombardo MV, Pierce K, Lewis NE. The ASD living biology: from cell proliferation to clinical phenotype. Mol Psychiatry. 2019;24:88\u2013107.","journal-title":"Mol Psychiatry"},{"key":"2967_CR73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/mp.2014.22","volume":"20","author":"K Brennand","year":"2015","unstructured":"Brennand K, Savas JN, Kim Y, Tran N, Simone A, Hashimoto-Torii K, et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol Psychiatry. 2015;20:361\u20138.","journal-title":"Mol Psychiatry"},{"key":"2967_CR74","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3945\/jn.109.113332","volume":"139","author":"E Ho","year":"2009","unstructured":"Ho E, Clarke JD, Dashwood RH. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr. 2009;139:2393\u20136.","journal-title":"J Nutr"},{"key":"2967_CR75","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M G\u00f6ttlicher","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 2001;20:6969\u201378.","journal-title":"EMBO J"},{"key":"2967_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.4218","volume":"31","author":"PD Thomas","year":"2022","unstructured":"Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31:8\u201322.","journal-title":"Protein Sci"},{"key":"2967_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8127","volume":"362","author":"MJ Gandal","year":"2018","unstructured":"Gandal MJ, Zhang P, Hadjimichael E, Walker RL, Chen C, Liu S, et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362:eaat8127.","journal-title":"Science"},{"key":"2967_CR78","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2015.06.034","volume":"162","author":"J Mariani","year":"2015","unstructured":"Mariani J, Coppola G, Zhang P, Abyzov A, Provini L, Tomasini L, et al. FOXG1-dependent dysregulation of GABA\/glutamate neuron differentiation in autism spectrum disorders. Cell. 2015;162:375\u201390.","journal-title":"Cell"},{"key":"2967_CR79","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1074\/jbc.M206911200","volume":"277","author":"HC Huang","year":"2002","unstructured":"Huang HC, Nguyen T, Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein Kinase C regulates antioxidant response element-mediated transcription*. J Biol Chem. 2002;277:42769\u201374.","journal-title":"J Biol Chem"},{"key":"2967_CR80","doi-asserted-by":"publisher","first-page":"105427","DOI":"10.1016\/j.nbd.2021.105427","volume":"157","author":"E Napoli","year":"2021","unstructured":"Napoli E, Flores A, Mansuri Y, Hagerman RJ, Giulivi C. Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome. Neurobiol Dis. 2021;157:105427.","journal-title":"Neurobiol Dis"},{"key":"2967_CR81","doi-asserted-by":"publisher","first-page":"1800795","DOI":"10.1002\/mnfr.201800795","volume":"63","author":"P Lei","year":"2019","unstructured":"Lei P, Tian S, Teng C, Huang L, Liu X, Wang J, et al. Sulforaphane improves lipid metabolism by enhancing mitochondrial function and biogenesis in vivo and in vitro. Mol Nutr Food Res. 2019;63:1800795.","journal-title":"Mol Nutr Food Res"},{"key":"2967_CR82","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.fct.2016.12.020","volume":"100","author":"M Negrette-Guzm\u00e1n","year":"2017","unstructured":"Negrette-Guzm\u00e1n M, Huerta-Yepez S, Vega MI, Le\u00f3n-Contreras JC, Hern\u00e1ndez-Pando R, Medina-Campos ON, et al. Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells. Food Chem Toxicol. 2017;100:90\u2013102.","journal-title":"Food Chem Toxicol"},{"key":"2967_CR83","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1093\/carcin\/bgs300","volume":"33","author":"B Singh","year":"2012","unstructured":"Singh B, Bhat HK. Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer. Carcinogenesis. 2012;33:2601\u201310.","journal-title":"Carcinogenesis"},{"key":"2967_CR84","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3390\/cancers12082197","volume":"12","author":"C Chang","year":"2020","unstructured":"Chang C, Worley BL, Pha\u00ebton R, Hempel N. Extracellular glutathione peroxidase GPx3 and its role in cancer. Cancers. 2020;12:2197.","journal-title":"Cancers"},{"key":"2967_CR85","doi-asserted-by":"publisher","first-page":"1378175","DOI":"10.1155\/2017\/1378175","volume":"2017","author":"C Lee","year":"2017","unstructured":"Lee C. Collaborative power of Nrf2 and PPAR\u03b3 activators against metabolic and drug-induced oxidative injury. Oxid Med Cell Longev. 2017;2017:1378175.","journal-title":"Oxid Med Cell Longev"},{"key":"2967_CR86","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca AM, Sloan SA, Clarke LE, Tian Y, Makinson CD, Huber N, et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015;12:671\u20138.","journal-title":"Nat Methods"},{"key":"2967_CR87","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.3390\/cells10102574","volume":"10","author":"ES Wilson","year":"2021","unstructured":"Wilson ES, Litwa K. Synaptic hyaluronan synthesis and CD44-mediated signaling coordinate neural circuit development. Cells. 2021;10:2574.","journal-title":"Cells"},{"key":"2967_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88750-2","volume":"11","author":"A Papariello","year":"2021","unstructured":"Papariello A, Taylor D, Soderstrom K, Litwa K. CB1 antagonism increases excitatory synaptogenesis in a cortical spheroid model of fetal brain development. Sci Rep. 2021;11:9356.","journal-title":"Sci Rep"},{"key":"2967_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25487-6","volume":"12","author":"S Watanabe","year":"2021","unstructured":"Watanabe S, Kurotani T, Oga T, Noguchi J, Isoda R, Nakagami A, et al. Functional and molecular characterization of a non-human primate model of autism spectrum disorder shows similarity with the human disease. Nat Commun. 2021;12:5388.","journal-title":"Nat Commun"},{"key":"2967_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.860275","volume":"15","author":"C Qi","year":"2022","unstructured":"Qi C, Chen A, Mao H, Hu E, Ge J, Ma G, et al. Excitatory and inhibitory synaptic imbalance caused by brain-derived neurotrophic factor deficits during development in a valproic acid mouse model of autism. Front Mol Neurosci. 2022;15:860275.","journal-title":"Front Mol Neurosci"},{"key":"2967_CR91","doi-asserted-by":"publisher","first-page":"e24149","DOI":"10.1371\/journal.pone.0024149","volume":"6","author":"JL Hodges","year":"2011","unstructured":"Hodges JL, Newell-Litwa K, Asmussen H, Vicente-Manzanares M, Horwitz AR. Myosin IIb activity and phosphorylation status determines dendritic spine and post-synaptic density morphology. PLoS ONE. 2011;6:e24149.","journal-title":"PLoS ONE"},{"key":"2967_CR92","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"PD Ray","year":"2012","unstructured":"Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981\u201390.","journal-title":"Cell Signal"},{"key":"2967_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11173","volume":"7","author":"BL Pearson","year":"2016","unstructured":"Pearson BL, Simon JM, McCoy ES, Salazar G, Fragola G, Zylka MJ. Identification of chemicals that mimic transcriptional changes associated with autism, brain aging and neurodegeneration. Nat Commun. 2016;7:11173.","journal-title":"Nat Commun"},{"key":"2967_CR94","doi-asserted-by":"publisher","first-page":"e3224","DOI":"10.1002\/brb3.3224","volume":"13","author":"M Saadat","year":"2023","unstructured":"Saadat M, Taherian AA, Aldaghi MR, Raise-Abdullahi P, Sameni HR, Vafaei AA. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain Behav. 2023;13:e3224.","journal-title":"Brain Behav"},{"key":"2967_CR95","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/ijms21113996","volume":"21","author":"N Eissa","year":"2020","unstructured":"Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, et al. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 alleviates autistic-like behaviors and oxidative stress in valproic acid induced autism in mice. Int J Mol Sci. 2020;21:3996.","journal-title":"Int J Mol Sci"},{"key":"2967_CR96","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat5314","volume":"368","author":"M Costa-Mattioli","year":"2020","unstructured":"Costa-Mattioli M, Walter P. The integrated stress response: from mechanism to disease. Science. 2020;368:eaat5314.","journal-title":"Science"},{"key":"2967_CR97","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","volume":"49","author":"KC Kim","year":"2014","unstructured":"Kim KC, Lee DK, Go HS, Kim P, Choi CS, Kim JW, et al. Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring. Mol Neurobiol. 2014;49:512\u201328.","journal-title":"Mol Neurobiol"},{"key":"2967_CR98","doi-asserted-by":"publisher","first-page":"712758","DOI":"10.1155\/2013\/712758","volume":"2013","author":"T Chomiak","year":"2013","unstructured":"Chomiak T, Turner N, Hu B. What we have learned about autism spectrum disorder from valproic acid. Pathol Res Int. 2013;2013:712758.","journal-title":"Pathol Res Int"},{"key":"2967_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41661-9","volume":"9","author":"T Kroon","year":"2019","unstructured":"Kroon T, van Hugte E, van Linge L, Mansvelder HD, Meredith RM. Early postnatal development of pyramidal neurons across layers of the mouse medial prefrontal cortex. Sci Rep. 2019;9:5037.","journal-title":"Sci Rep"},{"key":"2967_CR100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1113\/jphysiol.2012.235119","volume":"592","author":"C Lohmann","year":"2014","unstructured":"Lohmann C, Kessels HW. The developmental stages of synaptic plasticity. J Physiol. 2014;592:13\u201331.","journal-title":"J Physiol"},{"key":"2967_CR101","doi-asserted-by":"publisher","first-page":"148461","DOI":"10.1016\/j.brainres.2023.148461","volume":"1815","author":"A Hernandez","year":"2023","unstructured":"Hernandez A, Delgado-Gonz\u00e1lez E, Durairaj RV, Reyes-Haro D, Mart\u00ednez-Torres A, Espinosa F. Striatal synaptic changes and behavior in adult mouse upon prenatal exposure to valproic acid. Brain Res. 2023;1815:148461.","journal-title":"Brain Res"},{"key":"2967_CR102","doi-asserted-by":"publisher","first-page":"101739","DOI":"10.1016\/j.redox.2020.101739","volume":"37","author":"KKS Narasimhan","year":"2020","unstructured":"Narasimhan KKS, Devarajan A, Karan G, Sundaram S, Wang Q, van Groen T, et al. Reductive stress promotes protein aggregation and impairs neurogenesis. Redox Biol. 2020;37:101739.","journal-title":"Redox Biol"},{"key":"2967_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1168321","volume":"13","author":"M Asif Ali","year":"2023","unstructured":"Asif Ali M, Khan N, Kaleem N, Ahmad W, Alharethi SH, Alharbi B, et al. Anticancer properties of sulforaphane: current insights at the molecular level. Front Oncol. 2023;13:1168321.","journal-title":"Front Oncol"},{"key":"2967_CR104","doi-asserted-by":"publisher","first-page":"105283","DOI":"10.1016\/j.phrs.2020.105283","volume":"163","author":"EJ Calabrese","year":"2021","unstructured":"Calabrese EJ, Kozumbo WJ. The phytoprotective agent sulforaphane prevents inflammatory degenerative diseases and age-related pathologies via Nrf2-mediated hormesis. Pharmacol Res. 2021;163:105283.","journal-title":"Pharmacol Res"},{"key":"2967_CR105","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuron.2015.12.008","volume":"89","author":"JC Silbereis","year":"2016","unstructured":"Silbereis JC, Pochareddy S, Zhu Y, Li M, Sestan N. The cellular and molecular landscapes of the developing human central nervous system. Neuron. 2016;89:248\u201368.","journal-title":"Neuron"},{"key":"2967_CR106","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0166-2236(00)01813-0","volume":"24","author":"Y Ben-Ari","year":"2001","unstructured":"Ben-Ari Y. Developing networks play a similar melody. Trends Neurosci. 2001;24:353\u201360.","journal-title":"Trends Neurosci"},{"key":"2967_CR107","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1091\/mbc.e17-03-0209","volume":"28","author":"B Roberts","year":"2017","unstructured":"Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua MA, et al. Systematic gene tagging using CRISPR\/Cas9 in human stem cells to illuminate cell organization. Mol Biol Cell. 2017;28:2854\u201374.","journal-title":"Mol Biol Cell"},{"key":"2967_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910457","volume":"22","author":"K Tate","year":"2021","unstructured":"Tate K, Kirk B, Tseng A, Ulffers A, Litwa K. Effects of the selective serotonin reuptake inhibitor fluoxetine on developing neural circuits in a model of the human fetal cortex. Int J Mol Sci. 2021;22:10457.","journal-title":"Int J Mol Sci"},{"key":"2967_CR109","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"2967_CR110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"2967_CR111","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"The Gene Ontology Consortium, Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, et al. The Gene Ontology knowledgebase in 2023. Genetics. 2023;224:iyad031.","journal-title":"Genetics"},{"key":"2967_CR112","first-page":"e3990","volume":"11","author":"WP Bunner","year":"2021","unstructured":"Bunner WP, Dodson R, Hughes RM, Szatmari EM. Transfection and activation of CofActor, a light and stress gated optogenetic tool, in primary hippocampal neuron cultures. Bio-Protoc. 2021;11:e3990.","journal-title":"Bio-Protoc"},{"key":"2967_CR113","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/00031305.1990.10475712","volume":"44","author":"DJ Saville","year":"1990","unstructured":"Saville DJ. Multiple comparison procedures: the practical solution. Am Stat. 1990;44:174\u201380.","journal-title":"Am Stat"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02967-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02967-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:11:27Z","timestamp":1757160687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02967-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02967-5","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}